Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG

about

Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG

Item

http://www.wikidata.org/entity/Q59134868

description

im November 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Establishment of the first Int ...... capsular Vi polysaccharide IgG

@en

Establishment of the first Int ...... capsular Vi polysaccharide IgG

@nl

type

Item

label

Establishment of the first Int ...... capsular Vi polysaccharide IgG

@en

Establishment of the first Int ...... capsular Vi polysaccharide IgG

@nl

prefLabel

Establishment of the first Int ...... capsular Vi polysaccharide IgG

@en

Establishment of the first Int ...... capsular Vi polysaccharide IgG

@nl

P1476

Establishment of the first Int ...... capsular Vi polysaccharide IgG

@en

P2093

Akshay Goel

http://www.w3.org/2001/XMLSchema#string

Alastair Logan

http://www.w3.org/2001/XMLSchema#string

Andrew J Pollard

http://www.w3.org/2001/XMLSchema#string

Celina Jin

http://www.w3.org/2001/XMLSchema#string

David Goldblatt

http://www.w3.org/2001/XMLSchema#string

Eleanor Atkinson

http://www.w3.org/2001/XMLSchema#string

Haoyu Liang

http://www.w3.org/2001/XMLSchema#string

Jae Seung Yang

http://www.w3.org/2001/XMLSchema#string

Jason Hockley

http://www.w3.org/2001/XMLSchema#string

Marcela F Pasetti

http://www.w3.org/2001/XMLSchema#string

P2860

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam.

The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines.

Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.

Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers

A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned.

Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012.

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.

Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment.

Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.

P304

29-38

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOLOGICALS.2018.09.001

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30201529

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

bioengineering

biotechnology

P932

6238147

http://www.w3.org/2001/XMLSchema#string